CDC: influenza vaccine efficacy at 47% in adults, 61% in kids

  • Doyle JD & al.
  • MMWR Morb Mortal Wkly Rep
  • 15 Feb 2019

  • curated by Liz Scherer
  • Clinical Essentials
Access to the full content of this site is available only to registered healthcare professionals. Access to the full content of this site is available only to registered healthcare professionals.

Takeaway

  • Interim reports from CDC estimate that overall influenza vaccine effectiveness (VE) is 47% against laboratory-confirmed, medically attended influenza; higher VE seen in children.
  • Companion report shows influenza activity remains elevated, with A(H1N1) strain predominating nationwide; A(H3N2) predominates in Southeastern states.

Why this matters

  • Vaccination remains the most effective preventive tool against influenza-related illness, complications, and deaths, but improved coverage is needed to realize full potential.
  • Continue to offer/encourage vaccination to all unvaccinated patients ages >6 months as long as influenza viruses are circulating.

Key results

  • 14% (465/3245) of children/adults with acute respiratory infections (ARI) tested positive for influenza (98% influenza A, 2% influenza B).
  • 74% (293), 26% (101) of 394 subtyped influenza A viruses were A(H1N1)pdm09, A(H3N2), respectively.
  • Overall, 43% (198), 57% (1591) vaccinated persons were influenza-positive, -negative, respectively.
  • Adjusted VE against all medically attended influenza virus-associated ARI: 47% (95% CI, 34%-57%).
  • Adjusted VE for children, ages 6 months to 17 years: 61% (95% CI, 44%-73%).

Study design

  • Interim US Flu VE Network surveillance report evaluating VE against laboratory-confirmed influenza associated with medically attended ARI, November 23, 2018-February 2, 2019.
  • Funding: CDC.

Limitations

  • Small sample size.
  • Self-report bias; end-of-season VE may differ.
  • Observational.
  • Data limited to outpatient medical visits vs severe complications/hospitalizations.

Please confirm your acceptance

To gain full access to GPnotebook please confirm:

By submitting here you confirm that you have accepted Terms of Use and Privacy Policy of GPnotebook.

Submit